[Characteristics of immunomodulating effect of salmozan depending on the time of administration].
Kirillicheva
G B
GB
Solov'eva
M S
MS
Baturina
I G
IG
Pronin
A V
AV
Tumanian
M A
MA
D015720:5'-Nucleotidase / Q000378:metabolism*; D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D001202:Ascitic Fluid / Q000166:cytology; D002940:Circadian Rhythm; D017737:Macrophages, Peritoneal / Q000187:drug effects / Q000201:enzymology; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D011135:Polysaccharides, Bacterial / Q000494:pharmacology*
D000276:Adjuvants, Immunologic; D011135:Polysaccharides, Bacterial; C029023:salmozan; D015720:5'-Nucleotidase
Osobennosti immunomoduliruiushchego deĭstviia sal'mozana v zavisimosti ot vremeni vvedeviia.